Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 515)
Posted On: 05/01/2025 8:48:24 AM
Post# of 154678
Posted By: My69z
Leronlimab can/will create a new classification of treatment?

"Vaccines & Therapuetics"

Leronlimab has none of the drawbacks of each classification.

Add LL-PLS, vectoring ability & Roza's outstanding switch discovery.

If you treat as long as a vaccine.
Have none of therapuetic SAE's.

"monoclonial antibody" is vague.

How to medically profile LL ?

Create a new sub-class for it ??













(5)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site